We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$544M
AUM Growth
-$282M
Cap. Flow
-$349M
Cap. Flow %
-64.13%
Top 10 Hldgs %
79.89%
Holding
92
New
22
Increased
24
Reduced
24
Closed
15

Top Buys

Rank Stock Value
1
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$7.26M
2
CVS icon
CVS Health
CVS
+$4.32M
3
DVA icon
DaVita
DVA
+$4.15M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.58M
5
COR icon
Cencora
COR
+$1.61M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$20M
2
GM icon
General Motors
GM
+$9.4M
3
APTV icon
Aptiv
APTV
+$7.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.98M
5
BABA icon
Alibaba
BABA
+$3.84M

Sector Composition

Rank Sector Weight
1 Financials 10.88%
2 Healthcare 9.71%
3 Communication Services 4.67%
4 Materials 2.47%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUNTW
76
DELISTED
Hunter Maritime Acquisition Corp. Warrant
HUNTW
$8K ﹤0.01%
+50,000
New +$7.39K
APTV icon
77
Aptiv
APTV
$12.2B
– –
-125,000
Closed -$7.7M
BABA icon
78
Alibaba
BABA
$276B
– –
-28,000
Closed -$3.84M
BMY icon
79
Bristol-Myers Squibb
BMY
$124B
– –
-76,476
Closed -$3.98M
DD icon
80
DuPont de Nemours
DD
$18.3B
– –
-1,674
Closed -$227K
GM icon
81
General Motors
GM
$68.6B
– –
-281,031
Closed -$9.4M
HCA icon
82
HCA Healthcare
HCA
$82.3B
– –
-160,379
Closed -$20M
IVW icon
83
iShares S&P 500 Growth ETF
IVW
$73.1B
– –
-16,000
Closed -$603K
JNJ icon
84
CALL
Johnson & Johnson
JNJ
$609B
– –
-10,000
Closed -$1.29M
PFE icon
85
Pfizer
PFE
$143B
– –
-5,279
Closed -$219K
QQQ icon
86
PUT
Invesco QQQ Trust
QQQ
$462B
– –
-200,000
Closed -$30.9M
TLT icon
87
iShares 20+ Year Treasury Bond ETF
TLT
$42.8B
– –
-3,600
Closed -$437K
XLF icon
88
State Street Financial Select Sector SPDR ETF
XLF
$55.5B
– –
-25,000
Closed -$645K
ICPT
89
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-10,000
Closed -$1.01M
MXWL
90
CALL
DELISTED
Maxwell Technologies Inc
MXWL
– –
-307,200
Closed -$636K
VXX
91
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-75,000
Closed -$3.52M
1 2 3
4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, DSC Advisors held 92 positions worth $544M, down 34% from $826M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

DSC Advisors withdrew a net $349M in Q1 2019, closing 15 positions and reducing 24 holdings. Its most notable exit was HCA Healthcare, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DSC Advisors opened a new position in Foamix Pharmaceuticals Ltd. Ordinary Shares worth $7.27M.

  • DSC Advisors's largest Q1 2019 buy was Foamix Pharmaceuticals Ltd. Ordinary Shares: 1,937,724 shares worth $7.27M.
  • DSC Advisors added most to CVS Health in Q1 2019, an estimated $4.32M increase.
  • DSC Advisors's biggest Q1 2019 reduction was Alexion Pharmaceuticals, cutting an estimated $1.24M.
  • DSC Advisors fully exited HCA Healthcare in Q1 2019, selling an estimated $20M.
  • DSC Advisors's ten largest holdings make up 80% of its $544M portfolio in Q1 2019.
  • DSC Advisors opened 22 new positions and closed 15 in Q1 2019.
  • DSC Advisors's portfolio value fell 34% quarter-over-quarter to $544M.

Based on DSC Advisors's 13F filing for Q1 2019, filed 15 May 2019.